Unconfigured Ad

Collapse
X
 
  • Filter
  • Time
  • Show
Clear All
new posts
  • illumina
    Registered Vendor
    • Mar 2009
    • 8

    Bioinformatics Scientist – San Diego #2095

    Why is one person more likely to develop a disease—like cancer, diabetes or Parkinson’s—than someone else? Why would one person respond differently to treatment than another? Illumina’s technologies are helping researchers around the world to answer these questions and others, on a scale not even possible a few years ago.

    Illumina is the only life sciences company developing genome-wide technologies for genotyping, gene expression and sequencing—the three cornerstones of modern genetic analysis. By enabling studies of thousands of patient samples at once, our products set genetic discovery on fast forward. And we’re just getting started.

    Bioinformatics Scientist – San Diego #2095

    Illumina develops tools for the discovery of genetic variation and the analysis of its biological significance. We have developed assays for applications including sequencing, whole genome genotyping, gene expression, methylation, and copy number variation. We are seeking an exceptional individual to contribute to algorithm design and statistical data analysis for the large data sets being generated by these assays. Your responsibilities may include:

    • Analysis of sequencing data
    • Analysis of genotyping data
    • LOH and copy number analysis
    • Differential expression analysis
    • Experimental design
    • Methylation detection and quantification
    • Participation in collaborations
    • Publication in peer reviewed journals

    We seek demonstrated accomplishment in some or all of the following skills:
    • Sequence analysis
    • Innovative algorithm development
    • Applied statistics
    • Critical problem solving
    • Proficiency in R, matlab, and/or C/C++/C#
    • Superior communication skills

    Education
    • PhD in computer science, mathematics, statistics or equivalent
    • Biology knowledge strongly preferred
    • Postdoctoral experience preferred
    • Strong publication history

    When you join the high-performing team at Illumina, your work takes on new meaning—to an exponential degree. Our growth, our positive culture, and the impact our products are having in the world ignite a passion that drives our people forward. And together, we accomplish beyond expectations.

    experience the power of i
    www.illumina.com/careers
    Last edited by illumina; 11-18-2009, 10:02 AM.

Latest Articles

Collapse

  • SEQadmin2
    Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
    by SEQadmin2



    Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
    ...
    07-09-2026, 11:10 AM
  • SEQadmin2
    Cancer Drug Resistance: The Lingering Barrier to Rising Survival
    by SEQadmin2



    Cancer survival rates have significantly increased in the last few decades in the United States, reaching a combined 70% 5-year survival rate by 2021. Behind this number, there are years of research to find new therapies, drug targets, and early detection methods. But there is one core challenge that keeps slowing down these advances, and it’s about drug resistance.

    There is no single reason why many patients don’t respond to treatment as expected. Cancer is...
    07-08-2026, 05:17 AM
  • GATTACAT
    Reply to Nine Things a Sample Prep Scientist Thinks About Before Sequencing
    by GATTACAT
    Love this - good data definitely starts from good input, and poor input can only give relatively poor data. I particularly like the mention of Nanodrop/absorbance based methods for quantification. It's such a toss up if you'll get an accurate reading or what amounts to a randomly generated number, and a lot of library/sequencing related issues can be traced back to poor quant.
    07-01-2026, 11:43 AM

ad_right_rmr

Collapse

News

Collapse

Topics Statistics Last Post
Started by SEQadmin2, 07-13-2026, 10:26 AM
0 responses
27 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 07-09-2026, 10:04 AM
0 responses
37 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 07-08-2026, 10:08 AM
0 responses
24 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 07-07-2026, 11:05 AM
0 responses
34 views
0 reactions
Last Post SEQadmin2  
Working...